DS BIOPHARMA ABSTRACTS ACCEPTED AT THE ATOPIC DERMATITIS CENTRE OF REFERENCE AND EXCELLENCE (ADCARE) 2021 CONFERENCEDS BIOPHARMA ABSTRACTS ACCEPTED AT THE ATOPIC DERMATITIS CENTRE OF REFERENCE AND EXCELLENCE (ADCARE) 2021 CONFERENCEDS BIOPHARMA ABSTRACTS ACCEPTED AT THE ATOPIC DERMATITIS CENTRE OF REFERENCE AND EXCELLENCE (ADCARE) 2021 CONFERENCEDS BIOPHARMA ABSTRACTS ACCEPTED AT THE ATOPIC DERMATITIS CENTRE OF REFERENCE AND EXCELLENCE (ADCARE) 2021 CONFERENCE
  • Home
  • Non Pharmaceutical Portfolio
  • Partnering
  • Contact us
  • Home
  • Non Pharmaceutical Portfolio
  • Partnering
  • Contact us
✕

Media

  • Home
  • News
  • Media
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Events
  • Media
  • Press Releases
  • All
  • All
  • Adelle McGourty
  • micadmin
January 19, 2021

DS BIOPHARMA ABSTRACTS ACCEPTED AT THE ATOPIC DERMATITIS CENTRE OF REFERENCE AND EXCELLENCE (ADCARE) 2021 CONFERENCE

DS Biopharma (DS) has successfully submitted two abstracts to the Atopic Dermatitis Centre of Reference and Excellence (ADCARE) 2021 conference. A link to the abstract “Steroid-sparing […]
Do you like it?
Read more
November 19, 2019

Pipeline full with agents in various phases of development | Dermatology Times

The following article appeared in Dermatology Times on 19th November 2019: https://www.dermatologytimes.com/atopic-dermatitis/pipeline-full-agents-various-phases-development As dermatologists gain experience with newer atopic dermatitis medications, they’re getting glimpses of data […]
Do you like it?
Read more
  • About
  • Leadership
  • Careers
Copyright 2020 - DS Biopharma Limited, Trintech Building, South County Business Park, Leopardstown, Dublin 18, Ireland
Telephone: +353 1 2933 590 | Fax: +353 1 2176 117 | Email: info@dsbiopharma.com
  • Contact us